Early safety check for experimental drug BI 1569912
NCT ID NCT04445090
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This early-stage study tested a single dose of the experimental drug BI 1569912 in 68 healthy men to see if it is safe and how the body processes it. The study also looked at how food affects the drug's absorption. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Charité - Universitätsmedizin Berlin
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.